SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2024-03-18 13:11
Tx date 2024-03-13
$NGEN
NervGen Pharma Corp.
Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$100,000
+100,000 vol
$1.00 each
1,387,500
Filed 2024-03-18 13:11
Tx date 2024-03-13
$NGEN
NervGen Pharma Corp.
Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$100,000
+100,000 vol
$1.00 each
576,000
Filed 2024-03-12 14:15
Tx date 2024-03-12
$NGEN
NervGen Pharma Corp.
Bayley, Brian Eric
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$100,000
+100,000 vol
$1.00 each
400,000
Filed 2024-03-12 14:14
Tx date 2024-03-12
$NGEN
NervGen Pharma Corp.
Bayley, Brian Eric
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-100,000
-100,000 vol
$1.00 each
225,000
Filed 2024-03-12 14:11
Tx date 2024-03-11
$NGEN
NervGen Pharma Corp.
Bayley, Brian Eric
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$-450,000
-150,000 vol
$3.00 each
300,000
Filed 2024-02-27 01:05
Tx date 2024-02-22
$NGEN
NervGen Pharma Corp.
Punnett, Harold
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$100,000
+100,000 vol
$1.00 each
1,100,000
Filed 2024-02-27 00:29
Tx date 2024-02-22
$NGEN
NervGen Pharma Corp.
Punnett, Harold
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-100,000
-100,000 vol
$1.00 each
225,000
Filed 2024-02-21 00:12
Tx date 2024-02-19
$NGEN
NervGen Pharma Corp.
Adams, William James
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$278,400
+80,000 vol
$3.48 each
1,180,000
Filed 2024-02-21 00:06
Tx date 2024-02-19
$NGEN
NervGen Pharma Corp.
Mikol, Daniel
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$278,400
+80,000 vol
$3.48 each
1,010,000
Filed 2024-02-21 00:03
Tx date 2024-02-19
$NGEN
NervGen Pharma Corp.
Kelly, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$1,201,296
+345,200 vol
$3.48 each
3,207,200
Filed 2024-01-15 15:18
Tx date 2024-01-08
$NGEN
NervGen Pharma Corp.
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,977
+2,000 vol
$1.99 each
2,000
Filed 2024-01-08 13:59
Tx date 2024-01-08
$NGEN
NervGen Pharma Corp.
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,977
+2,000 vol
$1.99 each
Filed 2024-01-08 13:59
Tx date 2024-01-08
$NGEN
NervGen Pharma Corp.
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,977
+2,000 vol
$1.99 each
2,000
Filed 2024-01-08 13:56
Tx date 2021-09-09
$NGEN
NervGen Pharma Corp.
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2023-11-27 12:01
Tx date 2023-11-27
$NGEN
NervGen Pharma Corp.
Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus
$-1,920
-1,000 vol
$1.92 each
1,287,500
Filed 2023-10-20 17:42
Tx date 2023-10-16
$NGEN
NervGen Pharma Corp.
Ruffolo, John
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$262,500
+150,000 vol
$1.75 each
150,000
Filed 2023-10-20 17:39
Tx date 2023-10-16
$NGEN
NervGen Pharma Corp.
Ruffolo, John
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2023-10-20 17:37
Tx date 2023-10-16
$NGEN
NervGen Pharma Corp.
Ruffolo, John
4 - Director of Issuer
Holder: Carryn Ruffolo (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
27,027
Filed 2023-10-02 17:36
Tx date 2023-09-27
$NGEN
NervGen Pharma Corp.
Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-2,000
-1,000 vol
$2.00 each
1,288,500
Filed 2023-05-25 12:21
Tx date 2023-05-23
$NGEN
NervGen Pharma Corp.
Punnett, Harold
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$80,500
+50,000 vol
$1.61 each
325,000
Filed 2023-05-25 11:32
Tx date 2023-05-23
$NGEN
NervGen Pharma Corp.
Thompson, John Craig
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$80,500
+50,000 vol
$1.61 each
275,000
Filed 2023-05-25 11:16
Tx date 2023-05-23
$NGEN
NervGen Pharma Corp.
Ives, Glenn Antony
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$80,500
+50,000 vol
$1.61 each
300,000
Filed 2023-05-24 12:03
Tx date 2023-05-23
$NGEN
NervGen Pharma Corp.
Bayley, Brian Eric
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+50,000 vol
325,000
Filed 2023-05-24 11:53
Tx date 2023-05-23
$NGEN
NervGen Pharma Corp.
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$80,500
+50,000 vol
$1.61 each
225,000
Filed 2023-05-24 11:12
Tx date 2023-05-23
$NGEN
NervGen Pharma Corp.
Kaye, Randall
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$80,500
+50,000 vol
$1.61 each
375,000
Filed 2023-05-24 00:26
Tx date 2023-05-23
$NGEN
NervGen Pharma Corp.
Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$80,500
+50,000 vol
$1.61 each
476,000
Filed 2023-05-23 21:19
Tx date 2023-05-23
$NGEN
NervGen Pharma Corp.
Rogers, Adam
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
50 - Grant of options
$80,500
+50,000 vol
$1.61 each
300,000
Filed 2023-04-17 17:11
Tx date 2023-04-10
$NGEN
NervGen Pharma Corp.
Kelly, Michael
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$5,094,360
+2,862,000 vol
$1.78 each
2,862,000
Filed 2023-04-17 17:08
Tx date 2023-04-10
$NGEN
NervGen Pharma Corp.
Kelly, Michael
4 - Director of Issuer
Direct Ownership
Retention Securities
97 - Other
$1,050,200
+590,000 vol
$1.78 each
590,000
Filed 2023-04-17 17:00
Tx date 2023-04-10
$NGEN
NervGen Pharma Corp.
Kelly, Michael
4 - Director of Issuer
Direct Ownership
Retention Securities
00 - Opening Balance-Initial SEDI Report
Filed 2023-04-17 14:39
Tx date 2023-04-10
$NGEN
NervGen Pharma Corp.
Kelly, Michael
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2023-02-28 20:51
Tx date 2023-02-28
$NGEN
NervGen Pharma Corp.
Punnett, Harold
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
47 - Acquisition or disposition by gift

-1,450,000 vol
1,000,000
Filed 2023-02-28 10:49
Tx date 2023-02-28
$NGEN
NervGen Pharma Corp.
Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$116,400
+60,000 vol
$1.94 each
426,000
Filed 2023-02-24 21:42
Tx date 2023-02-22
$NGEN
NervGen Pharma Corp.
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$48,500
+25,000 vol
$1.94 each
175,000
Filed 2023-02-24 21:15
Tx date 2023-02-22
$NGEN
NervGen Pharma Corp.
Kaye, Randall
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$48,500
+25,000 vol
$1.94 each
325,000
Filed 2023-02-24 20:50
Tx date 2023-02-22
$NGEN
NervGen Pharma Corp.
Rogers, Adam
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
50 - Grant of options
$97,000
+50,000 vol
$1.94 each
250,000
Filed 2023-02-24 17:56
Tx date 2023-02-22
$NGEN
NervGen Pharma Corp.
Mikol, Daniel
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$155,200
+80,000 vol
$1.94 each
930,000
Filed 2023-02-24 17:26
Tx date 2023-02-22
$NGEN
NervGen Pharma Corp.
Thompson, John Craig
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$48,500
+25,000 vol
$1.94 each
225,000
Filed 2023-02-24 16:19
Tx date 2023-02-22
$NGEN
NervGen Pharma Corp.
Adams, William James
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$155,200
+80,000 vol
$1.94 each
1,100,000
Filed 2023-02-24 14:32
Tx date 2023-02-22
$NGEN
NervGen Pharma Corp.
Punnett, Harold
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$48,500
+25,000 vol
$1.94 each
275,000
Filed 2023-02-24 14:27
Tx date 2023-02-22
$NGEN
NervGen Pharma Corp.
Ives, Glenn Antony
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$97,000
+50,000 vol
$1.94 each
250,000
Filed 2023-02-24 13:44
Tx date 2023-02-23
$NGEN
NervGen Pharma Corp.
Bayley, Brian Eric
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+25,000 vol
275,000
Filed 2023-01-16 16:32
Tx date 2023-01-10
$NGEN
NervGen Pharma Corp.
Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
$-312,000
-150,000 vol
$2.08 each
366,000
Filed 2022-11-28 22:34
Tx date 2022-11-15
$NGEN
NervGen Pharma Corp.
Rogers, Adam
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
50 - Grant of options
$87,000
+50,000 vol
$1.74 each
200,000
Filed 2022-11-18 11:20
Tx date 2022-11-15
$NGEN
NervGen Pharma Corp.
Bayley, Brian Eric
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+50,000 vol
250,000
Filed 2022-11-18 10:27
Tx date 2022-11-15
$NGEN
NervGen Pharma Corp.
Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$87,000
+50,000 vol
$1.74 each
516,000
Filed 2022-11-17 17:14
Tx date 2022-11-15
$NGEN
NervGen Pharma Corp.
Thompson, John Craig
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$87,000
+50,000 vol
$1.74 each
200,000
Filed 2022-11-17 17:04
Tx date 2022-11-15
$NGEN
NervGen Pharma Corp.
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$87,000
+50,000 vol
$1.74 each
150,000
Filed 2022-11-17 17:03
Tx date 2022-11-15
$NGEN
NervGen Pharma Corp.
Kaye, Randall
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$87,000
+50,000 vol
$1.74 each
300,000
Filed 2022-11-17 16:58
Tx date 2022-11-15
$NGEN
NervGen Pharma Corp.
Punnett, Harold
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$87,000
+50,000 vol
$1.74 each
250,000
Filed 2022-11-17 16:54
Tx date 2022-11-15
$NGEN
NervGen Pharma Corp.
Ives, Glenn Antony
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$87,000
+50,000 vol
$1.74 each
200,000
Filed 2022-08-24 15:12
Tx date 2022-08-19
$NGEN
NervGen Pharma Corp.
Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-11,275
-5,500 vol
$2.05 each
1,289,500
Filed 2022-07-20 13:28
Tx date 2022-07-13
$NGEN
NervGen Pharma Corp.
PFP Biosciences Holdings LLC
3 - 10% Security Holder of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
5,000,000
Filed 2022-07-20 13:27
Tx date 2022-07-13
$NGEN
NervGen Pharma Corp.
PFP Biosciences Holdings LLC
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
10,000,000
Filed 2022-07-20 13:02
Tx date 2022-07-15
$NGEN
NervGen Pharma Corp.
Rogers, Adam
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
50 - Grant of options

+150,000 vol
150,000
Filed 2022-07-20 13:01
Tx date 2022-07-13
$NGEN
NervGen Pharma Corp.
Rogers, Adam
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2022-07-20 13:00
Tx date 2022-07-13
$NGEN
NervGen Pharma Corp.
Rogers, Adam
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
10,000
Filed 2022-07-20 12:57
Tx date 2022-07-13
$NGEN
NervGen Pharma Corp.
Rogers, Adam
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: PFP Biosciences Holdings LLC (Control or Direction)
Warrants
00 - Opening Balance-Initial SEDI Report
5,000,000
Filed 2022-07-20 12:54
Tx date 2022-07-13
$NGEN
NervGen Pharma Corp.
Rogers, Adam
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: PFP Biosciences Holdings LLC (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
10,000,000
Filed 2022-06-01 12:24
Tx date 2022-05-31
$NGEN
NervGen Pharma Corp.
Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$374,400
+180,000 vol
$2.08 each
466,000
Filed 2022-06-01 12:19
Tx date 2022-05-31
$NGEN
NervGen Pharma Corp.
Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
$-221,000
-100,000 vol
$2.21 each
286,000
Filed 2022-05-05 19:38
Tx date 2022-05-04
$NGEN
NervGen Pharma Corp.
Brennan, Paul Anthony
4 - Director of Issuer
Direct Ownership
Common Shares
54 - Exercise of warrants
$80,000
+50,000 vol
$1.60 each
619,354
Filed 2022-05-05 19:36
Tx date 2022-05-04
$NGEN
NervGen Pharma Corp.
Brennan, Paul Anthony
4 - Director of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants

-50,000 vol
9,676
Filed 2022-04-27 20:31
Tx date 2022-04-27
$NGEN
NervGen Pharma Corp.
Adams, William James
5 - Senior Officer of Issuer
Holder: RBCDS in Trust for William Adams (Indirect Ownership)
Common Shares
54 - Exercise of warrants
$76,800
+48,000 vol
$1.60 each
111,750
Filed 2022-04-27 20:24
Tx date 2022-04-27
$NGEN
NervGen Pharma Corp.
Adams, William James
5 - Senior Officer of Issuer
Holder: RBCDS in Trust for William Adams (Indirect Ownership)
Warrants
54 - Exercise of warrants

-48,000 vol
7,875
Filed 2022-04-27 20:02
Tx date 2022-04-26
$NGEN
NervGen Pharma Corp.
Punnett, Harold
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
54 - Exercise of warrants
$160,000
+100,000 vol
$1.60 each
2,450,000
Filed 2022-04-27 19:51
Tx date 2022-04-26
$NGEN
NervGen Pharma Corp.
Punnett, Harold
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants
$-160,000
-100,000 vol
$1.60 each
0
Filed 2022-04-27 19:47
Tx date 2022-04-26
$NGEN
NervGen Pharma Corp.
Punnett, Harold
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants
$160,000
+100,000 vol
$1.60 each
Filed 2022-04-27 19:45
Tx date 2020-05-20
$NGEN
NervGen Pharma Corp.
Punnett, Harold
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately

+100,000 vol
100,000
Filed 2022-04-27 19:43
Tx date 2017-01-19
$NGEN
NervGen Pharma Corp.
Punnett, Harold
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2022-04-26 15:33
Tx date 2022-04-26
$NGEN
NervGen Pharma Corp.
Bayley, Brian Eric
4 - Director of Issuer
Direct Ownership
Common Shares
54 - Exercise of warrants
$160,000
+100,000 vol
$1.60 each
450,000
Filed 2022-04-26 15:30
Tx date 2022-04-26
$NGEN
NervGen Pharma Corp.
Bayley, Brian Eric
4 - Director of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants
$-160,000
-100,000 vol
$1.60 each
0
Filed 2022-04-18 15:45
Tx date 2022-04-12
$NGEN
NervGen Pharma Corp.
Thompson, John Craig
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$330,000
+150,000 vol
$2.20 each
150,000
Filed 2022-04-18 15:43
Tx date 2022-04-12
$NGEN
NervGen Pharma Corp.
Thompson, John Craig
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2022-04-18 12:48
Tx date 2022-04-12
$NGEN
NervGen Pharma Corp.
Kaye, Randall
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$110,000
+50,000 vol
$2.20 each
250,000
Filed 2022-04-18 12:44
Tx date 2022-04-12
$NGEN
NervGen Pharma Corp.
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$110,000
+50,000 vol
$2.20 each
100,000
Filed 2022-04-18 12:42
Tx date 2022-04-12
$NGEN
NervGen Pharma Corp.
Ives, Glenn Antony
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$110,000
+50,000 vol
$2.20 each
150,000
Filed 2022-03-16 13:26
Tx date 2021-01-04
$NGEN
NervGen Pharma Corp.
Kaye, Randall
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$111,500
+50,000 vol
$2.23 each
150,000
Filed 2022-03-07 20:53
Tx date 2022-03-01
$NGEN
NervGen Pharma Corp.
Brennan, Paul Anthony
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$247,200
+120,000 vol
$2.06 each
1,110,000
Filed 2022-03-07 17:16
Tx date 2022-03-01
$NGEN
NervGen Pharma Corp.
Mikol, Daniel
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$103,000
+50,000 vol
$2.06 each
850,000
Filed 2022-03-07 16:44
Tx date 2022-03-01
$NGEN
NervGen Pharma Corp.
Adams, William James
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$164,800
+80,000 vol
$2.06 each
1,020,000
Filed 2021-11-29 13:16
Tx date 2021-11-29
$NGEN
NervGen Pharma Corp.
Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately

+80,000 vol
80,000
Filed 2021-11-29 13:15
Tx date 2019-02-19
$NGEN
NervGen Pharma Corp.
Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2021-11-29 13:12
Tx date 2021-11-29
$NGEN
NervGen Pharma Corp.
Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$208,000
+80,000 vol
$2.60 each
1,295,000
Filed 2021-09-16 16:09
Tx date 2021-09-13
$NGEN
NervGen Pharma Corp.
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$105,000
+50,000 vol
$2.10 each
50,000
Filed 2021-09-16 16:08
Tx date 2021-09-09
$NGEN
NervGen Pharma Corp.
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-09-16 16:07
Tx date 2021-09-09
$NGEN
NervGen Pharma Corp.
McKerracher, Krista
4 - Director of Issuer
Holder: Fig Advisory LLC (Indirect Ownership)
Options
00 - Opening Balance-Initial SEDI Report
100,000
Filed 2021-09-14 22:46
Tx date 2021-09-13
$NGEN
NervGen Pharma Corp.
Abrams, Michael Jeffrey
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$105,000
+50,000 vol
$2.10 each
300,000
Filed 2021-09-14 20:08
Tx date 2021-09-13
$NGEN
NervGen Pharma Corp.
Kaye, Randall
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$105,000
+50,000 vol
$2.10 each
150,000
Filed 2021-09-14 20:06
Tx date 2021-09-13
$NGEN
NervGen Pharma Corp.
Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$420,000
+200,000 vol
$2.10 each
386,000
Filed 2021-09-14 20:01
Tx date 2021-09-13
$NGEN
NervGen Pharma Corp.
Ives, Glenn Antony
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$210,000
+100,000 vol
$2.10 each
100,000
Filed 2021-09-14 18:15
Tx date 2021-09-13
$NGEN
NervGen Pharma Corp.
Punnett, Harold
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$105,000
+50,000 vol
$2.10 each
200,000
Filed 2021-09-13 21:22
Tx date 2021-09-12
$NGEN
NervGen Pharma Corp.
Punnett, Harold
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$105,000
+50,000 vol
$2.10 each
Filed 2021-09-13 17:50
Tx date 2021-09-12
$NGEN
NervGen Pharma Corp.
Ives, Glenn Antony
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$210,000
+100,000 vol
$2.10 each
Filed 2021-09-13 21:22
Tx date 2021-09-12
$NGEN
NervGen Pharma Corp.
Punnett, Harold
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$105,000
+50,000 vol
$2.10 each
200,000
Filed 2021-09-13 17:50
Tx date 2021-09-12
$NGEN
NervGen Pharma Corp.
Ives, Glenn Antony
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$210,000
+100,000 vol
$2.10 each
100,000
Filed 2021-09-13 17:37
Tx date 2021-09-09
$NGEN
NervGen Pharma Corp.
Ives, Glenn Antony
4 - Director of Issuer
Holder: Glenn Antony Ives Professional Corporatio (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
50,000
Filed 2021-09-13 17:27
Tx date 2021-09-09
$NGEN
NervGen Pharma Corp.
Ives, Glenn Antony
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-09-13 17:11
Tx date 2021-09-12
$NGEN
NervGen Pharma Corp.
Bayley, Brian Eric
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+50,000 vol
200,000
Filed 2021-08-28 13:30
Tx date 2021-08-24
$NGEN
NervGen Pharma Corp.
Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$-218,750
-125,000 vol
$1.75 each
1,215,000
Filed 2021-05-14 19:10
Tx date 2020-05-20
$NGEN
NervGen Pharma Corp.
Brennan, Paul Anthony
4 - Director of Issuer
Direct Ownership
Warrants
15 - Acquisition or disposition under a prospectus
$80,000
+50,000 vol
$1.60 each
50,000
Filed 2021-05-14 19:05
Tx date 2020-05-20
$NGEN
NervGen Pharma Corp.
Brennan, Paul Anthony
4 - Director of Issuer
Direct Ownership
Common Shares
53 - Grant of warrants
$80,000
+50,000 vol
$1.60 each
Filed 2021-05-14 18:43
Tx date 2021-05-12
$NGEN
NervGen Pharma Corp.
Brennan, Paul Anthony
4 - Director of Issuer
Direct Ownership
Warrants
15 - Acquisition or disposition under a prospectus
$20,319
+9,676 vol
$2.10 each
9,676
Filed 2021-05-14 18:39
Tx date 2019-11-26
$NGEN
NervGen Pharma Corp.
Brennan, Paul Anthony
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-14 18:25
Tx date 2021-05-12
$NGEN
NervGen Pharma Corp.
Brennan, Paul Anthony
4 - Director of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus
$29,998
+19,354 vol
$1.55 each
619,354
Filed 2021-05-14 13:55
Tx date 2021-05-12
$NGEN
NervGen Pharma Corp.
Adams, William James
5 - Senior Officer of Issuer
Holder: RBCDS in Trust for William Adams (Indirect Ownership)
Warrants
15 - Acquisition or disposition under a prospectus
$16,537
+7,875 vol
$2.10 each
55,875
Filed 2021-05-14 13:52
Tx date 2021-05-12
$NGEN
NervGen Pharma Corp.
Adams, William James
5 - Senior Officer of Issuer
Holder: RBCDS in Trust for William Adams (Indirect Ownership)
Common Shares
15 - Acquisition or disposition under a prospectus
$24,412
+15,750 vol
$1.55 each
63,750
Filed 2021-05-14 13:39
Tx date 2021-05-12
$NGEN
NervGen Pharma Corp.
Adams, William James
5 - Senior Officer of Issuer
Direct Ownership
Warrants
15 - Acquisition or disposition under a prospectus
$16,537
+7,875 vol
$2.10 each
Filed 2021-05-14 13:37
Tx date 2020-02-21
$NGEN
NervGen Pharma Corp.
Adams, William James
5 - Senior Officer of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-14 13:37
Tx date 2021-05-12
$NGEN
NervGen Pharma Corp.
Adams, William James
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus
$24,412
+15,750 vol
$1.55 each
Filed 2021-05-14 13:35
Tx date 2020-02-21
$NGEN
NervGen Pharma Corp.
Adams, William James
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2020-05-21 14:30
Tx date 2020-05-20
$NGEN
NervGen Pharma Corp.
Brennan, Paul Anthony
4 - Director of Issuer
Direct Ownership
Common Shares
53 - Grant of warrants
$80,000
+50,000 vol
$1.60 each
Filed 2021-05-10 14:22
Tx date 2021-05-05
$NGEN
NervGen Pharma Corp.
Mikol, Daniel
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
800,000
Filed 2021-05-06 20:08
Tx date 2021-04-23
$NGEN
NervGen Pharma Corp.
Brennan, Paul Anthony
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$198,000
+120,000 vol
$1.65 each
990,000
Filed 2021-05-06 19:34
Tx date 2021-04-23
$NGEN
NervGen Pharma Corp.
Adams, William James
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$132,000
+80,000 vol
$1.65 each
940,000
Filed 2020-11-02 11:41
Tx date 2020-10-26
$NGEN
NervGen Pharma Corp.
Kaye, Randall
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$176,000
+100,000 vol
$1.76 each
100,000
Filed 2020-11-02 11:38
Tx date 2020-10-26
$NGEN
NervGen Pharma Corp.
Kaye, Randall
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-10-29 18:09
Tx date 2020-10-26
$NGEN
NervGen Pharma Corp.
Kaye, Randall
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-10-29 18:09
Tx date 2020-10-26
$NGEN
NervGen Pharma Corp.
Kaye, Randall
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
100,000
Filed 2020-10-05 23:19
Tx date 2020-09-30
$NGEN
NervGen Pharma Corp.
Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$-585,000
-450,000 vol
$1.30 each
1,340,000
Filed 2020-08-20 22:45
Tx date 2020-05-22
$NGEN
NervGen Pharma Corp.
Punnett, Harold
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$175,000
+100,000 vol
$1.75 each
2,350,000
Filed 2020-06-05 12:24
Tx date 2020-06-03
$NGEN
NervGen Pharma Corp.
Punnett, Harold
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$135,000
+50,000 vol
$2.70 each
150,000
Filed 2020-06-04 21:07
Tx date 2020-06-03
$NGEN
NervGen Pharma Corp.
Franke, Amy
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
50 - Grant of options
$54,000
+20,000 vol
$2.70 each
272,000
Filed 2020-06-04 20:16
Tx date 2020-06-03
$NGEN
NervGen Pharma Corp.
Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$135,000
+50,000 vol
$2.70 each
186,000
Filed 2020-06-04 20:05
Tx date 2018-09-05
$NGEN
NervGen Pharma Corp.
Abrams, Michael Jeffrey
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$50,000
+100,000 vol
$0.50 each
200,000
Filed 2020-06-04 20:03
Tx date 2020-06-03
$NGEN
NervGen Pharma Corp.
Abrams, Michael Jeffrey
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$135,000
+50,000 vol
$2.70 each
250,000
Filed 2020-06-04 11:25
Tx date 2020-06-03
$NGEN
NervGen Pharma Corp.
Bayley, Brian Eric
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+50,000 vol
150,000
Filed 2020-05-22 17:40
Tx date 2020-05-20
$NGEN
NervGen Pharma Corp.
Bayley, Brian Eric
4 - Director of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately

+100,000 vol
100,000
Filed 2020-05-22 17:38
Tx date 2019-02-19
$NGEN
NervGen Pharma Corp.
Bayley, Brian Eric
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2020-05-22 17:37
Tx date 2020-05-20
$NGEN
NervGen Pharma Corp.
Bayley, Brian Eric
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$125,000
+100,000 vol
$1.25 each
350,000
Filed 2020-05-21 14:51
Tx date 2020-02-21
$NGEN
NervGen Pharma Corp.
Adams, William James
5 - Senior Officer of Issuer
Direct Ownership
Units
00 - Opening Balance-Initial SEDI Report
Filed 2020-05-21 14:50
Tx date 2020-05-20
$NGEN
NervGen Pharma Corp.
Adams, William James
5 - Senior Officer of Issuer
Direct Ownership
Units
16 - Acquisition or disposition under a prospectus exemption
$60,000
+48,000 vol
$1.25 each
Filed 2020-05-21 14:49
Tx date 2020-05-20
$NGEN
NervGen Pharma Corp.
Adams, William James
5 - Senior Officer of Issuer
Holder: RBCDS in Trust for William Adams (Indirect Ownership)
Warrants
16 - Acquisition or disposition under a prospectus exemption
$60,000
+48,000 vol
$1.25 each
48,000
Filed 2020-05-21 14:48
Tx date 2020-02-21
$NGEN
NervGen Pharma Corp.
Adams, William James
5 - Senior Officer of Issuer
Holder: RBCDS in Trust for William Adams (Indirect Ownership)
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2020-05-21 14:46
Tx date 2020-05-20
$NGEN
NervGen Pharma Corp.
Adams, William James
5 - Senior Officer of Issuer
Holder: RBCDS in Trust for William Adams (Indirect Ownership)
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$60,000
+48,000 vol
$1.25 each
48,000
Filed 2020-05-21 14:45
Tx date 2020-02-21
$NGEN
NervGen Pharma Corp.
Adams, William James
5 - Senior Officer of Issuer
Holder: RBCDS in Trust for William Adams (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2020-05-21 14:31
Tx date 2020-05-20
$NGEN
NervGen Pharma Corp.
Adams, William James
5 - Senior Officer of Issuer
Direct Ownership
Units
16 - Acquisition or disposition under a prospectus exemption
$60,000
+48,000 vol
$1.25 each
Filed 2020-05-21 14:30
Tx date 2020-05-20
$NGEN
NervGen Pharma Corp.
Brennan, Paul Anthony
4 - Director of Issuer
Direct Ownership
Common Shares
53 - Grant of warrants
$80,000
+50,000 vol
$1.60 each
600,000
Filed 2020-05-21 14:29
Tx date 2020-02-21
$NGEN
NervGen Pharma Corp.
Adams, William James
5 - Senior Officer of Issuer
Direct Ownership
Units
00 - Opening Balance-Initial SEDI Report
Filed 2020-05-21 14:28
Tx date 2020-05-20
$NGEN
NervGen Pharma Corp.
Brennan, Paul Anthony
4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$62,500
+50,000 vol
$1.25 each
550,000
Filed 2020-05-21 14:28
Tx date 2020-02-21
$NGEN
NervGen Pharma Corp.
Adams, William James
5 - Senior Officer of Issuer
Direct Ownership
Units
00 - Opening Balance-Initial SEDI Report
Filed 2020-04-15 11:42
Tx date 2020-04-06
$NGEN
NervGen Pharma Corp.
Brennan, Paul Anthony
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$79,099
+70,000 vol
$1.13 each
870,000
Filed 2020-04-15 11:07
Tx date 2020-04-06
$NGEN
NervGen Pharma Corp.
Franke, Amy
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
50 - Grant of options
$58,759
+52,000 vol
$1.13 each
252,000
Filed 2020-04-15 11:01
Tx date 2020-04-06
$NGEN
NervGen Pharma Corp.
Mackenzie, Lloyd
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$70,060
+62,000 vol
$1.13 each
512,000
Filed 2020-04-15 01:56
Tx date 2020-04-06
$NGEN
NervGen Pharma Corp.
Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$40,679
+36,000 vol
$1.13 each
136,000
Filed 2020-04-14 19:57
Tx date 2020-04-06
$NGEN
NervGen Pharma Corp.
Adams, William James
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$67,800
+60,000 vol
$1.13 each
860,000
Filed 2020-02-26 09:34
Tx date 2020-02-21
$NGEN
NervGen Pharma Corp.
Adams, William James
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+800,000 vol
800,000
Filed 2020-02-26 09:32
Tx date 2020-02-21
$NGEN
NervGen Pharma Corp.
Adams, William James
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-01-17 18:56
Tx date 2020-01-13
$NGEN
NervGen Pharma Corp.
Pilz, Robert
5 - Senior Officer of Issuer
Holder: Revelation Business Solutions Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-45,900
-15,000 vol
$3.06 each
292,500
Filed 2020-01-11 23:11
Tx date 2020-01-07
$NGEN
NervGen Pharma Corp.
Pilz, Robert
5 - Senior Officer of Issuer
Holder: Revelation Business Solutions Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-32,700
-15,000 vol
$2.18 each
307,500
Filed 2019-12-27 19:18
Tx date 2019-12-23
$NGEN
NervGen Pharma Corp.
Pilz, Robert
5 - Senior Officer of Issuer
Holder: Revelation Business Solutions Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-26,400
-15,000 vol
$1.76 each
322,500
Filed 2019-11-29 11:34
Tx date 2019-11-26
$NGEN
NervGen Pharma Corp.
Mackenzie, Lloyd
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
450,000
Filed 2019-11-29 11:32
Tx date 2019-11-26
$NGEN
NervGen Pharma Corp.
Mackenzie, Lloyd
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
250,000
Filed 2019-11-28 16:16
Tx date 2019-11-26
$NGEN
NervGen Pharma Corp.
Brennan, Paul Anthony
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
800,000
Filed 2019-11-28 16:14
Tx date 2019-11-26
$NGEN
NervGen Pharma Corp.
Brennan, Paul Anthony
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
500,000
Filed 2019-11-06 20:51
Tx date 2019-11-04
$NGEN
NervGen Pharma Corp.
Pilz, Robert
5 - Senior Officer of Issuer
Holder: Revelation Business Solutions Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-7,260
-4,400 vol
$1.65 each
337,500
Filed 2019-11-02 14:13
Tx date 2019-11-01
$NGEN
NervGen Pharma Corp.
Pilz, Robert
5 - Senior Officer of Issuer
Holder: Revelation Business Solutions Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-24,000
-15,000 vol
$1.60 each
341,900
Filed 2019-11-02 14:12
Tx date 2019-10-31
$NGEN
NervGen Pharma Corp.
Pilz, Robert
5 - Senior Officer of Issuer
Holder: Revelation Business Solutions Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-23,100
-15,000 vol
$1.54 each
356,900
Filed 2019-06-15 11:13
Tx date 2019-06-11
$NGEN
NervGen Pharma Corp.
Pilz, Robert
5 - Senior Officer of Issuer
Holder: Revelation Business Solutions Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-4,526
-3,100 vol
$1.46 each
371,900
Filed 2019-06-03 13:50
Tx date 2019-06-01
$NGEN
NervGen Pharma Corp.
Bosc, Denis
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
200,000
Filed 2019-06-03 11:53
Tx date 2019-06-01
$NGEN
NervGen Pharma Corp.
Franke, Amy
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
50 - Grant of options
$154,000
+100,000 vol
$1.54 each
200,000
Filed 2019-05-06 12:36
Tx date 2019-02-19
$NGEN
NervGen Pharma Corp.
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
100,000
Filed 2019-05-06 12:35
Tx date 2019-02-19
$NGEN
NervGen Pharma Corp.
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
1,500,000
Filed 2019-05-06 12:34
Tx date 2019-02-19
$NGEN
NervGen Pharma Corp.
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-05-06 12:34
Tx date 2019-02-19
$NGEN
NervGen Pharma Corp.
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$100,000
+100,000 vol
$1.00 each
Filed 2019-05-06 12:34
Tx date 2019-02-19
$NGEN
NervGen Pharma Corp.
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-05-06 12:33
Tx date 2019-02-19
$NGEN
NervGen Pharma Corp.
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$15,000
+1,500,000 vol
$0.01 each
Filed 2019-05-06 12:32
Tx date 2019-02-19
$NGEN
NervGen Pharma Corp.
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-05-06 12:32
Tx date 2019-02-19
$NGEN
NervGen Pharma Corp.
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-04-28 11:26
Tx date 2019-02-19
$NGEN
NervGen Pharma Corp.
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$100,000
+100,000 vol
$1.00 each
Filed 2019-04-28 11:19
Tx date 2019-02-19
$NGEN
NervGen Pharma Corp.
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$15,000
+1,500,000 vol
$0.01 each
Filed 2019-03-15 16:05
Tx date 2018-06-06
$NGEN
NervGen Pharma Corp.
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-03-15 16:03
Tx date 2018-06-06
$NGEN
NervGen Pharma Corp.
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-04-28 11:26
Tx date 2019-02-19
$NGEN
NervGen Pharma Corp.
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$100,000
+100,000 vol
$1.00 each
100,000
Filed 2019-04-28 11:23
Tx date 2019-01-17
$NGEN
NervGen Pharma Corp.
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$100,000
+100,000 vol
$1.00 each
Filed 2019-04-28 11:21
Tx date 2019-02-19
$NGEN
NervGen Pharma Corp.
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
97 - Other
$100,000
+100,000 vol
$1.00 each
Filed 2019-04-28 11:19
Tx date 2019-02-19
$NGEN
NervGen Pharma Corp.
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$15,000
+1,500,000 vol
$0.01 each
1,500,000
Filed 2019-04-28 11:18
Tx date 2018-06-19
$NGEN
NervGen Pharma Corp.
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$15,000
+1,500,000 vol
$0.01 each
Filed 2019-04-28 11:18
Tx date 2019-02-19
$NGEN
NervGen Pharma Corp.
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$15,000
+1,500,000 vol
$0.01 each
Filed 2019-04-28 11:16
Tx date 2019-02-19
$NGEN
NervGen Pharma Corp.
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$15,000
+1,500,000 vol
$0.01 each
Filed 2019-04-28 11:10
Tx date 2019-02-19
$NGEN
NervGen Pharma Corp.
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
97 - Other
$100,000
+100,000 vol
$1.00 each
Filed 2019-04-28 11:02
Tx date 2019-02-19
$NGEN
NervGen Pharma Corp.
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
97 - Other
$15,000
+1,500,000 vol
$0.01 each
Filed 2019-03-15 16:07
Tx date 2019-01-17
$NGEN
NervGen Pharma Corp.
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$100,000
+100,000 vol
$1.00 each
Filed 2019-03-15 16:04
Tx date 2018-06-19
$NGEN
NervGen Pharma Corp.
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$15,000
+1,500,000 vol
$0.01 each
Filed 2019-04-27 15:41
Tx date 2019-02-19
$NGEN
NervGen Pharma Corp.
Abrams, Michael Jeffrey
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
100,000
Filed 2019-04-27 15:39
Tx date 2018-08-21
$NGEN
NervGen Pharma Corp.
Abrams, Michael Jeffrey
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-04-27 15:38
Tx date 2018-09-05
$NGEN
NervGen Pharma Corp.
Abrams, Michael Jeffrey
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$50,000
+100,000 vol
$0.50 each
Filed 2019-04-27 15:34
Tx date 2019-02-19
$NGEN
NervGen Pharma Corp.
Pilz, Robert
5 - Senior Officer of Issuer
Holder: Revelation Business Solutions Ltd. (Indirect Ownership)
Options
00 - Opening Balance-Initial SEDI Report
100,000
Filed 2019-04-27 15:31
Tx date 2019-02-19
$NGEN
NervGen Pharma Corp.
Pilz, Robert
5 - Senior Officer of Issuer
Holder: Revelation Business Solutions Ltd. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
375,000
Filed 2019-04-27 15:21
Tx date 2018-06-11
$NGEN
NervGen Pharma Corp.
Pilz, Robert
5 - Senior Officer of Issuer
Holder: Revelation Business Solutions Ltd. (Indirect Ownership)
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-04-27 15:21
Tx date 2018-09-05
$NGEN
NervGen Pharma Corp.
Pilz, Robert
5 - Senior Officer of Issuer
Holder: Revelation Business Solutions Ltd. (Indirect Ownership)
Options
50 - Grant of options

+50,000 vol
Filed 2019-04-27 15:21
Tx date 2018-06-11
$NGEN
NervGen Pharma Corp.
Pilz, Robert
5 - Senior Officer of Issuer
Holder: Revelation Business Solutions Ltd. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-03-01 13:06
Tx date 2018-09-05
$NGEN
NervGen Pharma Corp.
Abrams, Michael Jeffrey
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$50,000
+100,000 vol
$0.50 each
Filed 2019-03-01 13:03
Tx date 2018-08-21
$NGEN
NervGen Pharma Corp.
Abrams, Michael Jeffrey
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-02-26 18:24
Tx date 2018-06-11
$NGEN
NervGen Pharma Corp.
Pilz, Robert
5 - Senior Officer of Issuer
Holder: Revelation Business Solutions Ltd. (Indirect Ownership)
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-02-26 18:21
Tx date 2018-09-05
$NGEN
NervGen Pharma Corp.
Pilz, Robert
5 - Senior Officer of Issuer
Holder: Revelation Business Solutions Ltd. (Indirect Ownership)
Options
50 - Grant of options

+50,000 vol
Filed 2019-02-26 18:18
Tx date 2018-06-11
$NGEN
NervGen Pharma Corp.
Pilz, Robert
5 - Senior Officer of Issuer
Holder: Revelation Business Solutions Ltd. (Indirect Ownership)
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-02-26 18:14
Tx date 2018-06-11
$NGEN
NervGen Pharma Corp.
Pilz, Robert
5 - Senior Officer of Issuer
Holder: Revelation Business Solutions Ltd. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-04-26 22:01
Tx date 2019-04-18
$NGEN
NervGen Pharma Corp.
Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-16,500
-10,000 vol
$1.65 each
1,790,000
Filed 2019-04-26 22:00
Tx date 2019-02-19
$NGEN
NervGen Pharma Corp.
Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
100,000
Filed 2019-04-26 21:58
Tx date 2019-02-19
$NGEN
NervGen Pharma Corp.
Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
1,800,000
Filed 2019-04-26 21:54
Tx date 2017-01-19
$NGEN
NervGen Pharma Corp.
Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-04-26 21:54
Tx date 2017-01-19
$NGEN
NervGen Pharma Corp.
Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-04-26 21:53
Tx date 2017-01-19
$NGEN
NervGen Pharma Corp.
Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-04-26 21:53
Tx date 2019-04-16
$NGEN
NervGen Pharma Corp.
Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-16,500
-10,000 vol
$1.65 each
Filed 2019-04-26 21:51
Tx date 2018-06-25
$NGEN
NervGen Pharma Corp.
Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$60,000
+300,000 vol
$0.20 each
Filed 2019-04-26 21:51
Tx date 2018-06-11
$NGEN
NervGen Pharma Corp.
Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$15,000
+1,500,000 vol
$0.01 each
Filed 2019-04-26 21:49
Tx date 2019-03-01
$NGEN
NervGen Pharma Corp.
Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$100,000
+100,000 vol
$1.00 each
Filed 2019-04-18 22:38
Tx date 2019-04-16
$NGEN
NervGen Pharma Corp.
Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-16,500
-10,000 vol
$1.65 each
Filed 2019-03-04 17:38
Tx date 2019-03-01
$NGEN
NervGen Pharma Corp.
Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$100,000
+100,000 vol
$1.00 each
Filed 2019-03-03 16:21
Tx date 2018-06-11
$NGEN
NervGen Pharma Corp.
Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$15,000
+1,500,000 vol
$0.01 each
Filed 2019-03-03 16:20
Tx date 2017-01-19
$NGEN
NervGen Pharma Corp.
Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-03-03 16:13
Tx date 2017-01-19
$NGEN
NervGen Pharma Corp.
Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-03-03 16:11
Tx date 2018-06-25
$NGEN
NervGen Pharma Corp.
Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$60,000
+300,000 vol
$0.20 each
Filed 2019-03-03 16:10
Tx date 2017-01-19
$NGEN
NervGen Pharma Corp.
Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-04-18 22:38
Tx date 2019-04-16
$NGEN
NervGen Pharma Corp.
Radvak, William Joseph
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-16,500
-10,000 vol
$1.65 each
1,790,000
Filed 2019-04-09 13:21
Tx date 2019-04-01
$NGEN
NervGen Pharma Corp.
Franke, Amy
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
100,000
Filed 2019-03-15
Tx date 2018-06-06
$NGEN
NervGen Pharma Corp.
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-03-15
Tx date 2019-01-17
$NGEN
NervGen Pharma Corp.
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$100,000
+100,000 vol
$1.00 each
100,000
Filed 2019-03-15
Tx date 2018-06-06
$NGEN
NervGen Pharma Corp.
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-03-15
Tx date 2018-06-19
$NGEN
NervGen Pharma Corp.
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$15,000
+1,500,000 vol
$0.01 each
1,500,000